Cancer diagnosis with normal blood tests
Pro Research Analysisby 
Searched over 200M research papers
Cancer Diagnosis with Normal Blood Tests: Limitations and Advances
Limitations of Standard Blood Tests in Cancer Diagnosis
Standard blood tests, such as full blood count (FBC), urea and electrolytes (U&E), and liver function tests (LFTs), are commonly used in primary care to support the diagnostic process for cancer. However, these tests are not always performed for every patient who is later diagnosed with cancer, and their use varies by cancer type, patient demographics, and presenting symptoms. For example, only about 41% of patients who were later diagnosed with cancer had at least one of these common blood tests before their diagnosis, and test use was much lower for cancers like melanoma compared to leukemia. Additionally, patients with clear "alarm" symptoms were less likely to have blood tests than those with non-specific symptoms. Importantly, the presence of normal blood test results does not rule out cancer, as many patients with cancer can have normal results, especially in the early stages or with certain cancer types 18.
Blood Test Trends and Their Association with Undiagnosed Cancer
Monitoring trends in blood test results over time, rather than relying on a single abnormal result, may provide more information for cancer risk assessment. Some studies have found that changes in certain blood test values, even within the normal range, can be early signals of cancer for specific types, such as bowel or pancreatic cancer. However, for many cancers, there is limited or no evidence that blood test trends are useful for early detection, and normal results are common in cancers like breast, prostate, and thyroid .
Advanced Blood-Based Tests for Early Cancer Detection
Recent advances in blood-based cancer screening have focused on detecting molecular markers, such as circulating tumor DNA (ctDNA) methylation patterns, protein biomarkers, and extracellular vesicle proteins. These tests can identify cancer signals even in asymptomatic individuals and often years before conventional diagnosis. For example, the PanSeer test detected five common cancers in 95% of asymptomatic individuals who were later diagnosed, up to four years before standard methods . Other tests, like CancerSEEK and multicancer early detection (MCED) assays, have shown high sensitivity and specificity for multiple cancer types, including those that are difficult to detect early with standard blood tests 3479+1 MORE.
Blood Test Use in Patients with Non-Specific Symptoms
In patients presenting with non-specific symptoms such as abdominal pain or bloating, abnormal results in common blood tests (e.g., raised inflammatory markers, platelets, or white blood cell count) can be early markers of cancer. However, these abnormalities are not always present, and many patients with cancer may still have normal blood tests prior to diagnosis. The likelihood of abnormal results increases closer to the time of diagnosis, but normal results do not exclude cancer, especially in the early stages .
Conclusion
Normal results from standard blood tests do not rule out cancer, as many patients—especially those with certain cancer types or early-stage disease—can have normal findings. While trends in blood test results and advanced molecular blood tests are improving early detection, there are still limitations, and further research is needed to refine these tools and understand their role in routine cancer screening and diagnosis. If cancer is suspected based on symptoms or risk factors, further investigation should not be delayed by normal blood test results 158.
Sources and full results
Most relevant research papers on this topic